Literature DB >> 11254238

Cytokine levels in serum of patients with juvenile rheumatoid arthritis.

M Yilmaz1, S G Kendirli, D Altintas, G Bingöl, B Antmen.   

Abstract

We investigated serum levels of interleukin (IL)-1beta, IL-6, IL-8, IL-12 and tumour necrosis factor (TNF)-alpha in JRA patients during both active and inactive phases of the disease. The systemic JRA patients had the highest IL-1beta and IL-6 levels during both active and inactive periods. In the systemic group IL-1beta, IL-6 and IL-12 levels during the active period were elevated compared to the inactive period (p = 0.0173, p = 0.0359 and p = 0.0117, respectively). Levels of these cytokines during the inactive stage were still greater than those of controls. IL-8 and TNF-alpha levels during both active and inactive periods were comparable to controls. IL-1beta correlated strongly with CRP and ESR (p = 0.008 and p = 0.031, respectively). IL-6 correlated significantly with CRP (p = 0.002). IL-12 levels were found to be correlated with ESR and CRP (p = 0.03 and p = 0.04, respectively). In active polyarticular JRA patients, IL-6 levels were elevated compared to the inactive phase, and the control (p = 0.001) IL-12 levels decreased significantly with clinical remission (p = 0.018). There was a strong correlation between 11-12 levels and number of joint with limited motion (p = 0). In oligoarticular JRA patients, IL-12 levels during active period were greater than in the controls and there was a marked decrease in IL-12 levels when the patients entered the inactive phase (p = 0.001) In conclusion, IL-1beta, IL-6 and IL-12 may play an important role in JRA and may be used as a marker of disease activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254238     DOI: 10.1007/s100670170100

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

Review 2.  The use of anakinra in juvenile arthritis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

3.  Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study.

Authors:  Ola A Abdul-Aziez; Nayera Z Saber; Samah A El-Bakry; Ahmed A Mohammad; Sahar S Abdel-Maksud; Yaser Ali
Journal:  Pak J Biol Sci       Date:  2010-02-01

4.  Correlation of mean platelet volume, neutrophil-to-lymphocyte ratio, and disease activity in children with juvenile ıdiopathic arthritis.

Authors:  Ali Güneş; Aydın Ece; Velat Şen; Ünal Uluca; Fesih Aktar; İlhan Tan; Servet Yel; İlyas Yolbaş
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Low cortisol levels in active juvenile idiopathic arthritis.

Authors:  Yelda Bilginer; Rezan Topaloglu; Ayfer Alikasifoglu; Nazli Kara; Nesrin Besbas; Seza Ozen; Aysin Bakkaloglu
Journal:  Clin Rheumatol       Date:  2009-12-15       Impact factor: 2.980

6.  Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro".

Authors:  Valéria F Caparbo; Flávia Prada; Clóvis A A Silva; Paula L Regio; Rosa M R Pereira
Journal:  Clin Rheumatol       Date:  2008-08-07       Impact factor: 2.980

7.  Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.

Authors:  Ruy Carrasco; Judith A Smith; Daniel Lovell
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 8.  Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.

Authors:  Kristen Hayward; Carol A Wallace
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

9.  Relationship between impaired apoptosis of lymphocytes and distribution of dendritic cells in peripheral blood and synovial fluid of children with juvenile idiopathic arthritis.

Authors:  Elzbieta Smolewska; Barbara Cebula; Henryka Brózik; Jerzy Stańczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-07-29       Impact factor: 4.291

10.  Challenges in the management of juvenile idiopathic arthritis with etanercept.

Authors:  Clare E Pain; Liza J McCann
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.